Osborne v. Az Medical Board ( 2017 )


Menu:
  •                      NOTICE: NOT FOR OFFICIAL PUBLICATION.
    UNDER ARIZONA RULE OF THE SUPREME COURT 111(c), THIS DECISION IS NOT PRECEDENTIAL
    AND MAY BE CITED ONLY AS AUTHORIZED BY RULE.
    IN THE
    ARIZONA COURT OF APPEALS
    DIVISION ONE
    ROBERT C. OSBORNE, Plaintiff/Appellant,
    v.
    ARIZONA MEDICAL BOARD, Defendant/Appellee.
    No. 1 CA-CV 16-0250
    FILED 6-13-2017
    Appeal from the Superior Court in Maricopa County
    No. LC 2014-000407-001
    The Honorable Crane McClennen, Judge (Retired)
    AFFIRMED
    COUNSEL
    Waterfall, Economidis, Caldwell, Hanshaw and Villamana PC, Tucson
    By James W. Stuehringer
    Counsel for Plaintiff/Appellant
    Arizona Attorney General’s Office, Phoenix
    By Michael Raine, Anne Froedge
    Counsel for Defendant/Appellee
    OSBORNE v. AZ MEDICAL BOARD
    Decision of the Court
    MEMORANDUM DECISION
    Presiding Judge Margaret H. Downie delivered the decision of the Court,
    in which Judge Kenton D. Jones and Judge Donn Kessler joined.
    D O W N I E, Judge:
    ¶1            Robert C. Osborne (“Appellant”) appeals the superior
    court’s order upholding the revocation of his license to practice medicine
    in Arizona by the Arizona Medical Board (“Board”). For the following
    reasons, we affirm.
    FACTS AND PROCEDURAL HISTORY
    ¶2            The Board began investigating Appellant — a Board-
    certified anesthesiologist with a pain-management practice — after
    receiving a complaint from another physician expressing concern about
    possible “dangerous prescribing practices” as to patients SM and SJ and
    advising that the Arizona State Board of Pharmacy’s prescription
    monitoring database (“CSPMP”) revealed “extraordinarily high and
    potentially lethal doses of opioid analgesics filled for these patients as
    prescribed by Dr. Osborne.” The Board forwarded the complaint to
    Appellant and asked him to respond and provide the patients’ medical
    records. Appellant submitted the requested records and response.
    ¶3            Jerome Julian Grove, M.D., who is board-certified in
    anesthesiology and pain management, reviewed the matter as an outside
    medical consultant for the Board. Dr. Grove identified several concerns,
    including: (1) opioid levels “excessive for the amount of pathology” noted
    in the patients’ medical records; (2) inadequate opioid management; (3)
    inadequate communication with the patients’ psychiatric treatment
    providers and lack of a “multidisciplinary approach;” and (4)
    unaddressed “red flags” regarding both patients.
    ¶4           The Board also asked Richard J. Ruskin, M.D. — a board-
    certified anesthesiologist with a subspecialty certification in pain
    management — to offer an assessment. Dr. Ruskin opined that Appellant
    deviated from the standard of care in several respects and identified both
    actual and potential harm, including “perpetuat[ing] a situation of
    extreme opioid dependence in SM” and rendering SJ “extremely opioid
    2
    OSBORNE v. AZ MEDICAL BOARD
    Decision of the Court
    dependent for reasons that . . . were totally unnecessary and grossly
    inappropriate.”
    ¶5            The Board filed a formal complaint against Appellant,
    alleging violations of Arizona Revised Statutes (“A.R.S.”) sections 32-
    1401(27)(e) (“[f]ailing or refusing to maintain adequate records on a
    patient”) and 32-1401(27)(q) (“[a]ny conduct or practice that is or might be
    harmful or dangerous to the health of the patient or the public”). A five-
    day administrative hearing ensued before an administrative law judge
    (“ALJ”).
    ¶6           The ALJ recommended that the Board revoke Appellant’s
    medical license. She found clear and convincing evidence that Appellant
    deviated from the standard of care in treating SM as follows:
       “[F]ailing to provide a coherent and organized history,
    physical examination, assessment, and plan of care . . . .”
       “[F]ailing to more thoroughly consider what other treatment
    modalities might be available rather than continuing to
    escalate SM’s opioid dosage.”
       “[F]ailing to document a clear rationale as to why
    [Appellant] felt it was necessary to accelerate SM’s opioid
    dosage to the level of 600 morphine mg-equivalents per
    day.”
       “[F]ailing to take into account [SM’s] co-morbid conditions,
    including her 10-year history of methamphetamine
    addiction, as well as bipolar disorder, and failing to contact
    SM’s behavioral health specialists in order to discuss these
    conditions in light of the high opioid doses she was
    requiring.”
       “[F]ailing to recognize and intervene when there were clear
    signs of opioid misuse and diversion, including violations of
    SM’s opioid agreement by the use of multiple pharmacies,
    SM’s report of taking diverted methadone, and SM’s report
    that her medication had been stolen by her son.”
    3
    OSBORNE v. AZ MEDICAL BOARD
    Decision of the Court
       Failing to maintain adequate records in violation of A.R.S.
    § 32-1401(2).1
    The ALJ also found clear and convincing evidence that Appellant deviated
    from the standard of care in treating SJ as follows:
       “[F]ailing to provide a coherent and organized history,
    physical examination, assessment, and plan of care . . . .”
       “[F]ailing to provide clear justification as to why it was
    necessary to maintain SJ on the equivalent of almost 900 mg
    of morphine a day.”
       “[F]ailing to clarify SJ’s co-morbid conditions and work
    more closely with her rheumatologist and primary care
    physicians.”
       “[F]ailing to more carefully consider what additional
    treatment modalities might have been available to SJ other
    than high-dose opioids.”
       Failing to maintain adequate records as required by A.R.S.
    § 32-1401(2).
    ¶7           The ALJ concluded Appellant had engaged in
    unprofessional conduct, as defined by A.R.S. § 32-1401(27)(q), and
    violated A.R.S. § 32-1401(2). In addressing the appropriate sanction, the
    ALJ cited the statutory directive that the Board “consider all previous
    nondisciplinary and disciplinary actions against a licensee,” A.R.S. § 32-
    1451(U), and discussed prior Board matters involving Appellant. In 2009,
    Appellant agreed to a letter of reprimand for violating the same statutes at
    issue here. As to one patient in that case — MG — Appellant stipulated:
    The standard of care when prescribing medications for
    chronic non-malignant pain requires a physician to perform
    1      Appellant does not challenge the determination that he failed to
    maintain adequate records as to both SM and SJ, so we do not address that
    issue. See MT Builders, L.L.C. v. Fisher Roofing, Inc., 
    219 Ariz. 297
    , 304 n.7,
    ¶ 19 (App. 2008) (arguments not developed on appeal are deemed
    waived).
    4
    OSBORNE v. AZ MEDICAL BOARD
    Decision of the Court
    an appropriate evaluation, to communicate and coordinate
    with the referring physician, to periodically assess the need
    for continued treatment and to investigate the patient for
    non-compliance. The standard of care also requires a
    physician to consider a new finding when increasing the
    dosage for opioids.
    [Appellant] deviated from the standard of care because he
    did not perform an appropriate evaluation, he did not
    communicate and coordinate with MG’s referring physician,
    he did not periodically assess MG’s need for continued
    treatment, he did not investigate MG for non-compliance
    and he did not consider a new finding when he increased
    the dosage of MG’s opioid medication.
    Appellant also agreed that his deviation from the standard of care “could
    have caused MG to suffer an inadvertent or purposeful prescription
    opioid overdose.”
    ¶8           In the same 2009 proceeding, Appellant admitted violating
    the standard of care as to three other patients “because he did not
    properly evaluate the patients, he did not communicate and coordinate
    with their prescribing physicians, he did not consider a multidisciplinary
    approach, and he did not closely monitor the patients for non-compliance
    or diversion.” And in 2010, the Board issued Appellant an Order for
    Continuing Medical Education for “prescribing extremely high doses of
    oxycodone to a high risk patient with a previous history of self medication
    and psychiatric issues in violation of A.R.S. § 32-1401(27)(q).”
    ¶9            Based on Appellant’s disciplinary history, “in addition to
    [his] repeated acts of unprofessional conduct,” the ALJ concluded that he
    “engages in conduct or practices that are or might be harmful or
    dangerous to the health of his patients or the public.” The ALJ
    recommended that the Board revoke Appellant’s license.
    ¶10           Counsel for the Board asked the Board to adopt the ALJ’s
    findings of fact, conclusions of law, and recommended order and to add
    findings and conclusions that more specifically addressed the harm or
    potential harm caused by Appellant’s conduct. The Board unanimously
    adopted the ALJ’s findings of fact, as well as the additional proposed
    finding of fact regarding harm, adopted the ALJ’s conclusions of law
    without modification, and issued an order revoking Appellant’s medical
    5
    OSBORNE v. AZ MEDICAL BOARD
    Decision of the Court
    license. After unsuccessfully seeking rehearing, Appellant appealed to the
    superior court.
    ¶11           Appellant asked the superior court to hold an evidentiary
    hearing, which it declined to do. After the superior court affirmed the
    Board’s order, Appellant timely appealed to this Court. We have
    jurisdiction pursuant to A.R.S. §§ 12-120.21(A)(1), -2101(A)(1), and -913.
    DISCUSSION
    ¶12          Appellant identifies four issues on appeal:
    (1) Whether the Board’s “decision was unsupported by
    substantial evidence and contrary to law because it
    failed to follow Webb [v. State ex rel. Ariz. Bd. of Med.
    Exam’rs, 
    202 Ariz. 555
    (App. 2002)]’s narrowing
    construction of A.R.S. §32-1401(27)(q) thereby applying
    the statute to Dr. Osborne in an unconstitutionally
    vague manner.”
    (2) Whether the Board’s “decision violated due process and
    was an abuse of discretion because it failed to consider
    supplemental evidence which went to the heart of [the
    Board’s] criticism of Dr. Osborne’s care and treatment of
    patient SM.”
    (3) Whether the Board’s “decision to adopt credibility
    findings regarding testifying patient SM was contrary to
    law and an abuse of discretion.”
    (4) Whether Appellant’s “rights to due process were
    violated when the court below refused to conduct an
    evidentiary hearing to determine if any of the [Board’s]
    investigative hierarchy communicated with any Board
    member regarding the Department of Justice and the
    DEA’s criminal investigation of Dr. Osborne.”
    We view the record in the light most favorable to upholding the Board’s
    decision. Golob v. Ariz. Med. Bd., 
    217 Ariz. 505
    , 507 n.1, ¶ 1 (App. 2008).
    Substantial evidence exists to support an administrative decision “even if
    the record also supports a different conclusion.” Ritland v. Ariz. State Bd.
    of Med. Exam’rs, 
    213 Ariz. 187
    , 189, ¶ 7 (App. 2006).
    6
    OSBORNE v. AZ MEDICAL BOARD
    Decision of the Court
    I.    A.R.S. § 32-1401(27)(q) Violation
    ¶13          The Board concluded Appellant violated A.R.S. § 32-
    1401(27)(q), which includes within the definition of “unprofessional
    conduct” any “conduct or practice that is or might be harmful or
    dangerous to the health of the patient or the public.” Appellant contends
    the Board applied this statute “in an unconstitutionally vague manner.”
    We review questions of law and issues of statutory interpretation de novo.
    
    Webb, 202 Ariz. at 557
    , ¶ 7.
    ¶14           In Webb, we noted the breadth of the “might be harmful or
    dangerous” language in § 32-1401(27)(q).2 
    Id. at 561,
    ¶ 25. We observed
    that there is “potential for harm in most prescriptive medication; and
    some forms of treatment – radiation and chemotherapy, to name two –
    involve near certainty of harm, yet harm accepted and acceptable in the
    effort to alleviate still greater harm.” 
    Id. Interpreting the
    statute in a
    manner comporting with due process, we held that it applies only to
    “those forms of treatment whose potential or actual harm is unreasonable
    under the circumstances, given the applicable standard of care.” 
    Id. at ¶
    27.
    ¶15             Neither the relevant statutes nor Webb requires the Board to
    make an express finding that potential or actual harm is “unreasonable
    under the circumstances.” “The legislature knows how to make written
    findings a requirement.” Hart v. Hart, 
    220 Ariz. 183
    , 187, ¶ 17 (App. 2009);
    see, e.g., A.R.S. §§ 13-702(B) (requiring factual findings on aggravating or
    mitigating factors); 25-403(B) (mandating specific findings in contested
    legal decision-making or parenting time matters); 8-538(A) (factual
    findings required when terminating parental rights). We note, however,
    that such a finding is not difficult to make, and in cases presenting a close
    call as to the reasonableness of harm specifically found by the Board,
    would assist reviewing courts in determining its adherence to the
    statutory standard. As we discuss infra, though, this case presents no such
    “close call.”
    ¶16          In its supplemental finding of fact, the Board stated: (1)
    “Both Dr. Ruskin and Dr. Grove testified that SM was harmed by
    [Appellant’s] conduct in that she was placed in a situation of extreme
    opioid dependence;” (2) “Dr. Ruskin stated in his report that patient SJ
    2     Webb interpreted an earlier version of the statute, though the
    relevant language remains unchanged.
    7
    OSBORNE v. AZ MEDICAL BOARD
    Decision of the Court
    was unnecessarily rendered extremely opioid dependent, as well;” and (3)
    “[T]here was the potential for overdose and death.” Although the first
    two findings could be construed as mere recitations of witness testimony,
    read in context, the Board is clearly adopting the quoted testimony as
    findings of fact. Moreover, the express finding that “there was the
    potential for overdose and death” clearly satisfies the requirement that the
    statute be applied only to treatment “whose potential or actual harm is
    unreasonable under the circumstances, given the applicable standard of
    care.” 
    Webb, 202 Ariz. at 561
    , ¶ 27. Appellant does not suggest that
    potential overdose or death was reasonable under the circumstances for
    either patient. Indeed, at oral argument before this Court, Appellant
    conceded that, “If a patient had died, that would not be reasonable.”
    ¶17           The Board’s supplemental finding is sufficient to comply
    with Webb, and the record supports that finding. When SM began treating
    with Appellant, she was taking five oxycodone 30 mg tablets per day. At
    SM’s second appointment, Appellant wrote that she was “stabilized on
    her medications,” yet he doubled her prescription to ten 30 mg tablets per
    day, writing that, “I have slightly increased her medications and will try to
    be supportive of her.” (Emphasis added). Appellant later increased SM’s
    dosage again — to 360 tablets per month — although a progress note
    states she was “stabilized on her medicine” with no “undercurrent
    changes.”
    ¶18            The Board could reasonably conclude there was no
    justification for or documentation explaining the substantial increases in
    opioids. Dr. Ruskin testified that instead of exploring alternative
    treatment modalities, Appellant simply prescribed “opioids, [and] more
    opioids.” When questioned about harm, Dr. Ruskin testified that SM
    “was put in a situation of extreme opioid dependence” and that “[d]eath
    from opioid overdose, whether it be intentional or unintentional, that’s
    clearly a risk.” He stated that “short of death, you have issues of
    morbidity, ending up in the emergency room, requiring treatment for
    drug overdose, requiring treatment for side effects related to opioid
    therapy . . . [and] the potential for addiction.” At the conclusion of Dr.
    Ruskin’s cross-examination, the following exchange occurred:
    Q.     It’s your belief that Dr. Osborne put SM at the risk of
    death?
    A.     Yes.
    Q.     And you say that because of the level of opioids?
    8
    OSBORNE v. AZ MEDICAL BOARD
    Decision of the Court
    A.     I say that because of the level of opioids primarily,
    yes.
    Q.     Even though there’s no ceiling for opioids, correct?
    A.     I’m not sure what that means. It still kills people.
    Q.     All right.
    A.     That’s a ceiling.
    ¶19           The record also substantiates that although SM was under
    psychiatric care (including prescribed medications) for bipolar disorder
    and had a ten-year history of methamphetamine abuse, Appellant did not
    coordinate with her mental health providers, despite evidence that
    psychiatric disease “is a known risk factor for opioid addiction and
    abuse.” The risks were heightened by SM signing a document that
    prohibited Appellant from sharing information with her other healthcare
    providers, which Dr. Grove testified was a “tremendous concern” because
    psychiatric medications interact with pain medications, and Appellant
    would need to communicate with this “high risk” patient’s mental health
    providers, or at the very least, “have that avenue open.”
    ¶20          Evidence also established Appellant’s failure to recognize
    and intervene in the face of “clear signs” of opioid misuse and diversion
    by SM. Appellant had SM sign an opioid agreement that stated:
    I agree not to obtain any narcotics from any other physician
    unless you are notified. I agree to obtain narcotics from only
    one pharmacy at a time, and will inform you of any change
    in pharmacy use.
    Testimony established the importance of using only one pharmacy as a
    means of tracking a patient’s medication usage due to the lack of
    communication between pharmacies.           During a three-month span
    preceding her treatment with Appellant, SM received opioid prescriptions
    from 11 different providers and filled those prescriptions at four different
    pharmacies. And while treating with Appellant, SM violated the opioid
    agreement by filling her prescriptions at multiple pharmacies and
    obtaining narcotics from other prescribers. Nothing in Appellant’s
    records indicate “he was aware of or had addressed the violations of the
    narcotics agreement with SM.”
    9
    OSBORNE v. AZ MEDICAL BOARD
    Decision of the Court
    ¶21           SM also consistently sought early refills, suggesting she was
    using her medications in excess of prescribed dosages. Appellant did not
    question her about this issue. After running out of her medication on one
    occasion, SM took methadone obtained from another person. Appellant
    advised her that was “unacceptable” and required her to drug-test as a
    result. According to Dr. Grove, SM’s conduct was “extremely concerning
    and would typically completely change my plan of care for that patient.”
    On a different occasion, SM reported that her son had stolen her
    medication. Dr. Grove testified that, given these red flags, Appellant fell
    below the standard of care in obtaining only four drug screens during his
    treatment of SM.
    ¶22           Patient SJ saw Appellant for more than four years for
    chronic pain. The only plan of care evident from Appellant’s records was
    a regimen of opioids that escalated over time. Dr. Grove testified it was
    inappropriate to expose SJ to such amounts of “highly addictive
    substances.” He further opined that Appellant’s “level of assessment in
    terms of the toxicology” was substandard and that the combination of SJ’s
    medications could have caused respiratory depression or death.
    ¶23            Testimony established that SJ’s history of sexual abuse and
    illicit drug use raised red flags and that sexual abuse “is a known variable
    for risk stratification for mismanagement of medications.” As with SM,
    Appellant did not address SJ’s violations of her opioid agreement after she
    obtained prescriptions from multiple pharmacies. Nor did he address SJ’s
    repeated early refills. Appellant documented an incident in which SJ
    reported that her dog got into her purse and destroyed her pills.
    Appellant wrote in her record that he was “very critical of this. This is her
    only chance.” Dr. Grove described this incident as a possible indication of
    diversion or addiction and testified that Appellant fell below the standard
    of care by asking SJ to submit to only one drug screen that pre-dated the
    report of a dog destroying her opioids.
    ¶24          We are not faced here with “a physician who came to work
    with a head cold,” 
    Webb, 202 Ariz. at 561
    , ¶ 24, or a record suggesting only
    harm or potential harm reasonable under the circumstances. On the
    contrary, substantial evidence established unreasonable potential harm
    caused by Appellant’s deviations from the standard of care, including
    death and overdose. Under these circumstances, we reject Appellant’s
    contention that A.R.S. § 32-1401(27)(q), as applied by the Board, violated
    his due process rights.
    10
    OSBORNE v. AZ MEDICAL BOARD
    Decision of the Court
    II.      Motion to Supplement Administrative Record
    ¶25           After the evidentiary hearing before the ALJ concluded,
    Appellant moved to supplement the administrative record with evidence
    he described as newly discovered. The evidence — all of which was
    created after the hearing — consisted of SM’s medical records from other
    healthcare providers, an operative report of surgery occurring after the
    hearing, and Appellant’s own records regarding SM’s post-hearing visits.
    The Board opposed the motion, and the ALJ denied it.
    ¶26          In arguing he was deprived of an opportunity to present a
    complete defense, in violation of due process, Appellant cites the
    following finding by the ALJ:
    At the time of the hearing, close to four years after SM began
    treatment with [Appellant], she had not had the
    recommended surgery.
    Contrary to Appellant’s assertion, the ALJ’s finding is not “simply
    untrue.” It is undisputed that SM did not undergo surgery until after the
    hearing. Moreover, the quoted finding appears in the context of a
    discussion about Appellant’s failure “to more thoroughly consider what
    other treatment modalities might be available rather than continuing to
    escalate [SM’s] opioid dosage.” The point the outside medical consultants
    and Board were making is that, for almost four years, Appellant failed to
    revisit or amend his initial treatment plan for SM — smoking cessation
    and surgery — focusing instead on an escalating dosage of narcotics
    without explanation or justification. Under these circumstances, we agree
    with the Board that “[a]dmitting evidence of an eventual surgery would
    not have changed the experts’ opinions about the four years of treatment
    before surgery.”
    III.     SM’s Credibility
    ¶27           Appellant next contends the Board erred by adopting the
    ALJ’s credibility findings regarding SM. We disagree.
    ¶28            In discussing the theft of opioids by SM’s son, the ALJ
    found:
    SM’s testimony on this issue was inconsistent. SM first
    testified that she was hospitalized for seven days in August
    2011, and that her medications were stolen during her
    hospitalization. When the Board’s counsel pointed out that
    11
    OSBORNE v. AZ MEDICAL BOARD
    Decision of the Court
    SM had been hospitalized for seven days in June 2011, SM
    then reported she was hospitalized again in August 2011.3
    During an interview with [Appellant’s] counsel on October
    18, 2013, SM stated she and her husband had gone to a
    casino in Tucson and discovered the medications were
    missing when they returned.
    In her conclusions of law, the ALJ stated:
    SM’s inconsistency as to when the medications were taken
    by her son calls into question the veracity of her story. Had
    [Appellant] more clearly recorded in his progress notes the
    report he received from SM regarding the incident, there
    would be a contemporaneous version of events that could
    have shed more light on the events.
    ¶29           Because the ALJ observes the demeanor and attitude of
    witnesses, “the Board should give deference to [her] credibility findings”
    and may “overrule these findings only if it finds evidence in the record for
    so doing.” 
    Ritland, 213 Ariz. at 191
    , ¶ 14. A reviewing court should
    uphold a Board’s credibility finding “if there is substantial evidence in the
    record supporting it.” 
    Id. at 191–92,
    ¶ 15.
    ¶30            Appellant’s contention that the ALJ “failed to take into
    account SM’s mental health issues and periodic confusion” is, in essence, a
    request to reweigh the ALJ’s first-hand observations and come to a
    contrary conclusion. However, nothing in the record or the law required
    the Board to do so. The record does not support Appellant’s suggestion
    that the ALJ disregarded the entirety of SM’s testimony based on the
    questionable veracity of her story about the medication theft. The
    credibility finding expressly relates to that one incident, and the ALJ
    credited other testimony by SM in her findings.
    IV.    Request for Evidentiary Hearing in Superior Court
    ¶31         Finally, Appellant challenges the denial of his request for an
    evidentiary hearing in the superior court to explore the Board’s
    involvement in or knowledge about ongoing criminal investigations of
    him being conducted by the Department of Justice and Drug Enforcement
    3      SM further testified she could not remember the dates of her
    hospitalizations because the medication she was taking made her memory
    “really foggy.”
    12
    OSBORNE v. AZ MEDICAL BOARD
    Decision of the Court
    Administration. In his superior court filings, Appellant contended the
    Board withheld information from him about communications with
    investigating law enforcement entities, while providing Dr. Ruskin (and
    perhaps others) with such information.             The Board denied these
    allegations, avowing that the “previously hidden information” notation in
    its internal files referred to the fact it did not give Dr. Ruskin the report
    authored by Dr. Grove or the Staff Investigational Review Committee
    (“SIRC”) report before he submitted his initial report.
    ¶32            The superior court ordered the Board to disclose documents
    relevant to this issue and permitted Appellant to depose Board
    Investigator Elle Steger. The Board complied. Appellant thereafter filed a
    renewed request for an evidentiary hearing, which the court denied. We
    review that ruling for an abuse of discretion. Any Charity Unlimited, LLC
    v. Ariz. Dep’t of Transp., No 1 CA-CV 14-0789, 
    2016 WL 2909386
    , at * 9, ¶ 38
    (App. May 19, 2016).
    ¶33           Steger testified that she did not speak with any Board
    member, Dr. Ruskin, or the ALJ regarding ongoing criminal
    investigations. In terms of the “previously hidden information” notation,
    she explained that the phrase referred to the Grove and SIRC reports that
    were initially withheld from Dr. Ruskin so as not to compromise his
    independent assessment. She testified that Board members had no access
    to internal documents referring to a “US Department of Justice request” or
    to communications Board staff had with investigating entities.
    ¶34           There is no evidence or inference that any Board member,
    Dr. Ruskin, or the ALJ considered, or even had knowledge of the ongoing
    criminal investigations of Appellant. The documents produced pursuant
    to the superior court’s order revealed only that Board staff members
    communicated with law enforcement. “Without a showing of actual bias
    or prejudice,” Board members and the ALJ are presumed to be fair.
    Lathrop v. Ariz. Bd. of Chiropractic Exam’rs, 
    182 Ariz. 172
    , 180 (App. 1995);
    see also Hourani v. Benson Hosp., 
    211 Ariz. 427
    , 433, ¶ 21 (App. 2005) (“All
    decision makers, judges and administrative tribunals alike, are entitled to
    a presumption of ‘honesty and integrity.’” (citation omitted)). “[M]ere
    speculation regarding bias” is insufficient to rebut the presumption.
    Pavlik v. Chinle Unified Sch. Dist. No. 24, 
    195 Ariz. 148
    , 152, ¶ 11 (App.
    1999).
    ¶35           The evidentiary hearing contemplated by A.R.S. § 12-910
    offers a “safety net for the unusual case in which new evidence, had it
    been presented in the administrative proceeding, would have changed the
    13
    OSBORNE v. AZ MEDICAL BOARD
    Decision of the Court
    decision.” Shaffer v. Ariz. State Liquor Bd., 
    197 Ariz. 405
    , 409, ¶ 18 (App.
    2000). Nothing in the record suggests that an evidentiary hearing was
    necessary for the superior court to make its statutorily required
    determinations. See A.R.S. § 12-910(A), (E) (“[T]he court shall hold an
    evidentiary hearing . . . to the extent necessary to make the determination”
    whether the agency’s action was unsupported by substantial evidence,
    contrary to law, arbitrary and capricious, or an abuse of discretion.).
    Under these circumstances, the court did not abuse its discretion by
    denying Appellant’s requests for an evidentiary hearing.
    CONCLUSION
    ¶36        For the foregoing reasons, we affirm the decision of the
    Arizona Medical Board.
    AMY M. WOOD • Clerk of the Court
    FILED: AA
    14